ConductScience.org, home
Study to Evaluate the Efficacy and Safety of APL-2 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
API referenceFor AI assistants

Trial · NCT03500549

Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Run-in Period (Day -28 to ≤Day 1)STARTEDPegcetacoplan to Pegcetacoplan41
Run-in Period (Day -28 to ≤Day 1)STARTEDEculizumab to Pegcetacoplan39
Run-in Period (Day -28 to ≤Day 1)COMPLETEDPegcetacoplan to Pegcetacoplan41
Run-in Period (Day -28 to ≤Day 1)COMPLETEDEculizumab to Pegcetacoplan39
Run-in Period (Day -28 to ≤Day 1)NOT COMPLETEDPegcetacoplan to Pegcetacoplan0
Run-in Period (Day -28 to ≤Day 1)NOT COMPLETEDEculizumab to Pegcetacoplan0
RCP (Day 1 - Week 16)STARTEDPegcetacoplan to Pegcetacoplan41
RCP (Day 1 - Week 16)STARTEDEculizumab to Pegcetacoplan39
RCP (Day 1 - Week 16)COMPLETEDPegcetacoplan to Pegcetacoplan38
RCP (Day 1 - Week 16)COMPLETEDEculizumab to Pegcetacoplan39
RCP (Day 1 - Week 16)NOT COMPLETEDPegcetacoplan to Pegcetacoplan3
RCP (Day 1 - Week 16)NOT COMPLETEDEculizumab to Pegcetacoplan0
Open-label Period (Week 17 to Week 48)STARTEDPegcetacoplan to Pegcetacoplan38
Open-label Period (Week 17 to Week 48)STARTEDEculizumab to Pegcetacoplan39
Open-label Period (Week 17 to Week 48)COMPLETEDPegcetacoplan to Pegcetacoplan35
Open-label Period (Week 17 to Week 48)COMPLETEDEculizumab to Pegcetacoplan32
Open-label Period (Week 17 to Week 48)NOT COMPLETEDPegcetacoplan to Pegcetacoplan3
Open-label Period (Week 17 to Week 48)NOT COMPLETEDEculizumab to Pegcetacoplan7

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03500549/flow

API referenceFor AI assistants